IPO registrations (S-1, F-1) · Registrants
ABEONA THERAPEUTICS INC.
- SEC CIK
- 318306 · filings on EDGAR ↗
- Name on the registration
- PLASMATECH BIOPHARMACEUTICALS INC
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC (2014–2015); ACCESS PHARMACEUTICALS INC (1996–2014); CHEMEX PHARMACEUTICALS INC (1995–1996)
- Registration
- Form S-1, first filed 2005-05-31, last 2014-12-04; 8 initial registrations, 20 amendments
- Outcome
- Final prospectus filed 2005-06-16; declared effective 2006-08-07; withdrawal requested 2007-12-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, Cleveland, OH 44103
- EIN
- 83-0221517
- Ticker
- ABEO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ABEONA THERAPEUTICS INC. on the corporate pages
On this site
- Business registration: ABEONA THERAPEUTICS INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ABEONA THERAPEUTICS INC. Fuzzy (name and state)
- Business registration: ABEONA THERAPEUTICS INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ABEONA THERAPEUTICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: ABEONA THERAPEUTICS INC. Fuzzy (name and state)
- Form D issuer: PLASMATECH BIOPHARMACEUTICALS INC EXACT (CIK (EXACT))
- SEC filer: ABEONA THERAPEUTICS INC. EXACT (CIK (EXACT))
Filings 47
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-05-31 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0000950135-05-003085 ↗ |
| 2005-06-13 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000950135-05-003251 ↗ |
| 2005-06-16 | 424B4 | 424B4 (final prospectus) | ACCESS PHARMACEUTICALS INC | 0000950135-05-003368 ↗ |
| 2006-07-13 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0001104659-06-046724 ↗ |
| 2006-08-07 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-06-001090 ↗ |
| 2007-05-08 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-07-001807 ↗ |
| 2007-07-23 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-07-002927 ↗ |
| 2007-12-26 | RW | RW (withdrawal request) | ACCESS PHARMACEUTICALS INC | 0000318306-07-000066 ↗ |
| 2008-03-11 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0001140361-08-006400 ↗ |
| 2008-10-08 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-08-000058 ↗ |
| 2008-11-13 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-08-003378 ↗ |
| 2008-12-11 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-08-003659 ↗ |
| 2009-10-27 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0000318306-09-000029 ↗ |
| 2009-12-02 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-09-000036 ↗ |
| 2010-01-15 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000002 ↗ |
| 2010-01-21 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000007 ↗ |
| 2010-01-21 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-10-000272 ↗ |
| 2010-01-25 | 424B1 | 424B1 (final prospectus) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000011 ↗ |
| 2010-04-12 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000020 ↗ |
| 2010-04-12 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000023 ↗ |
| 2010-04-29 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-10-001222 ↗ |
| 2010-05-03 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000048 ↗ |
| 2010-07-09 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000055 ↗ |
| 2010-08-24 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000060 ↗ |
| 2010-11-15 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000069 ↗ |
| 2010-11-23 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000074 ↗ |
| 2010-12-08 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000078 ↗ |
| 2010-12-08 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-10-003488 ↗ |
| 2010-12-14 | 424B1 | 424B1 (final prospectus) | ACCESS PHARMACEUTICALS INC | 0000318306-10-000082 ↗ |
| 2011-12-09 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0000318306-11-000029 ↗ |
| 2012-01-17 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-12-000005 ↗ |
| 2012-01-19 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-12-000007 ↗ |
| 2012-01-20 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-12-000237 ↗ |
| 2012-02-21 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0000318306-12-000017 ↗ |
| 2012-03-30 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-12-000024 ↗ |
| 2012-04-09 | EFFECT | EFFECT (declared effective) | ACCESS PHARMACEUTICALS INC | 9999999995-12-000972 ↗ |
| 2012-05-08 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-12-000034 ↗ |
| 2012-06-25 | S-1/A | S-1/A (amendment) | ACCESS PHARMACEUTICALS INC | 0000318306-12-000045 ↗ |
| 2014-07-02 | S-1 | S-1 (registration) | ACCESS PHARMACEUTICALS INC | 0001144204-14-041164 ↗ |
| 2014-10-24 | S-1/A | S-1/A (amendment) | PLASMATECH BIOPHARMACEUTICALS INC | 0001144204-14-062643 ↗ |
| 2014-11-06 | S-1/A | S-1/A (amendment) | PLASMATECH BIOPHARMACEUTICALS INC | 0001144204-14-065560 ↗ |
| 2014-12-04 | S-1/A | S-1/A (amendment) | PLASMATECH BIOPHARMACEUTICALS INC | 0001144204-14-072184 ↗ |
| 2014-12-18 | EFFECT | EFFECT (declared effective) | PLASMATECH BIOPHARMACEUTICALS INC | 9999999995-14-003732 ↗ |
| 2014-12-22 | 424B4 | 424B4 (final prospectus) | PLASMATECH BIOPHARMACEUTICALS INC | 0001144204-14-075385 ↗ |
| 2015-06-04 | EFFECT | EFFECT (declared effective) | PLASMATECH BIOPHARMACEUTICALS INC | 9999999995-15-001534 ↗ |
| 2015-07-23 | EFFECT | EFFECT (declared effective) | ABEONA THERAPEUTICS INC. | 9999999995-15-002036 ↗ |
| 2016-09-15 | EFFECT | EFFECT (declared effective) | ABEONA THERAPEUTICS INC. | 9999999995-16-005695 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Alvino Mark | Director | 34 | 2006–2026 | ||
| Jeffrey B Davis | Director; Director,Officer; Officer | CEO; Cheif Operating Officer; Chief Executive Officer; Chief Operating Officer; COO | 15 | 2006–2017 | |
| Rouhandeh Steven H | Director,Officer,TenPercentOwner; Director,TenPercentOwner; TenPercentOwner | Executive Chairman | 33 | 2006–2021 | |
| SCO CAPITAL PARTNERS LLC | Director,TenPercentOwner; TenPercentOwner | 23 | 2006–2021 | ||
| LUCI DAVID P | Director | 3 | 2007–2009 | ||
| MAZANET ROSEMARY | Director | 1 | 2007 | ||
| SEILER STEPHEN R | Director,Officer | President and CEO; President & CEO | 2 | 2007 | |
| Beach Capital LLC | TenPercentOwner | 10 | 2007–2014 | ||
| SCO CAPITAL PARTNERS L P | TenPercentOwner | 4 | 2007–2008 | ||
| NOWOTNIK DAVID P | Officer | Sr Vice President R&D; Sr VP R&D; Sr. VP R&D | 6 | 2008–2012 | |
| THOMPSON STEPHEN B | Officer | CFO; Chief Financial Officer; Sr VP Finance; Vice President Finance; VP Finance-Chief Acctg Officer; VP-Finance Chief Acctg Officer | 11 | 2008–2017 | |
| FEINBERG LARRY N | TenPercentOwner | 1 | 2008 | ||
| Oracle Associates LLC | TenPercentOwner | 2 | 2008 | ||
| ORACLE INSTITUTIONAL PARTNERS L P | TenPercentOwner | 2 | 2008 | ||
| ORACLE INVESTMENT MANAGEMENT INC | TenPercentOwner | 2 | 2008 | ||
| ORACLE PARTNERS LP | TenPercentOwner | 2 | 2008 | ||
| ACM Capital Partners, LLC | TenPercentOwner | 3 | 2011–2012 | ||
| Ayer Capital Management, LP | TenPercentOwner | 3 | 2011–2012 | ||
| Ayer Capital Partners, LLC | TenPercentOwner | 3 | 2011–2012 | ||
| Venkatesan Jay | TenPercentOwner | 3 | 2011–2012 | ||
| Ahn Mark J | Director | 7 | 2015–2016 | ||
| Wider Todd | Director | 21 | 2015–2022 | ||
| Miller Timothy J | Director,Officer; Officer | President & CEO; See Remarks | 2 | 2017–2019 | |
| Thiel Carsten | Officer | Chief Executive Officer | 2 | 2018 | |
| Buono Stefano | Director | 6 | 2018–2020 | ||
| Van Duyne Richard B | Director | 4 | 2018–2019 | ||
| Howell Stephen B. | Director | 5 | 2019–2020 | ||
| CARR EDWARD | Officer | Chief Accounting Officer; Chief Financial Officer; Vice President, Controller | 13 | 2019–2021 | |
| Siffert Joao MD | Director,Officer; Officer | Chief Executive Officer; Interim CEO | 5 | 2019–2020 | |
| Silverstein Christine Berni | Director; Director,Officer; Officer | Chief Financial Officer | 18 | 2019–2026 | |
| Pereira Brian JG | Director,Officer | Executive Chairman | 2 | 2020 | |
| Tomasello Shawn | Director | 2 | 2020 | ||
| Mann Paul Elliot | Director | 12 | 2020–2022 | ||
| MIGAUSKY GEORGE V | Director | 2 | 2020 | ||
| Amoroso Michael | Director; Director,Officer; Officer | Chief Executive Officer; Chief Operating Officer; COO | 18 | 2020–2026 | |
| Charles Faith L. | Director | 11 | 2021–2026 | ||
| Alland Leila | Director | 12 | 2021–2026 | ||
| Wuchterl Donald A. | Director | 10 | 2021–2026 | ||
| Seshadri Vishwas | Director,Officer; Officer | Chief Executive Officer; SVP, Head of Res./Clin. Dev. | 32 | 2021–2026 | |
| O'Malley Brendan M. | Officer | SVP, Chief Legal Officer; SVP, General Counsel | 34 | 2021–2026 | |
| Vazzano Joseph Walter | Officer | Chief Financial Officer | 31 | 2022–2026 | |
| Adage Capital Management, L.P. | TenPercentOwner | 2 | 2023–2024 | ||
| ADAGE CAPITAL PARTNERS GP, L.L.C. | TenPercentOwner | 1 | 2023 | ||
| Adage Capital Partners, L.P. | TenPercentOwner | 1 | 2023 | ||
| Atchinson Robert | TenPercentOwner | 2 | 2023–2024 | ||
| Gross Phillip | TenPercentOwner | 2 | 2023–2024 | ||
| Crombez Eric | Director | 7 | 2024–2026 | ||
| Zeiher Bernhardt G | Director | 4 | 2024–2026 | ||
| Vasanthavada Madhav | Officer | Chief Commercial Officer | 7 | 2026 | |
| Goldan Keith A. | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-06-01 | PLASMATECH BIOPHARMACEUTICALS INC | Pharmaceuticals | $22,664,509 | $13,664,509 | 17 | 1 |
| 2015-05-22 | PLASMATECH BIOPHARMACEUTICALS INC | Pharmaceuticals | $10,000,000 | $10,000,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.